Evaluation and significance of tetracycline stability in rabies vaccine baits.

Tetracycline is widely used as a biomarker for bait consumption by wildlife; tetracycline is incorporated into bones and teeth and can be detected by fluorescence microscopy several weeks postconsumption. During 2003, the United States Department of Agriculture distributed more than 10 million tetracycline-containing rabies-vaccine baits to control the spread of wildlife vectored rabies to humans, pets, and livestock. To estimate the percentage of target species consuming the baits, raccoons and skunks were collected in baited areas and teeth were analyzed for the presence of the biomarker. Several incidents of low biomarker detection rates prompted an investigation of the stability of the biomarker in the baits. Baits were collected at several points along the manufacturing and distribution chain. Baits were analyzed for free and polymer-bound tetracycline and the less active isomer epitetracycline. Results indicated that a portion of the tetracycline was converted to epitetracycline. Additionally, significant quantities of both compounds were trapped in the polymer, which is homogeneously distributed throughout the bait. The results of this study suggest that approximately 40% of the target quantity of tetracycline was unavailable for absorption. This situation could contribute to low biomarker detection rates and suggests that formulation modification should be considered.

Hy-Line W-36 and Hy-Line W-98 laying hens respond similarly to dietary phosphorus levels.

Two experiments were conducted to determine if 2 laying hen strains, Hy-Line W-36 and Hy-Line W-98, would respond similarly to being fed corn-soybean meal diets (17% CP and 3.8% Ca) deficient in nonphytate P (NPP). In experiment 1, 3 diets with varying NPP levels (0.10, 0.14, and 0.45%) were fed to 6 replicate groups of 12 hens of each Hy-Line strain from 20 to 50 wk of age. Body weight, egg weight, egg mass, feed intake, and NPP intake were higher for W-98 hens compared with W-36 hens throughout the 30-wk period. The 0.10% NPP dietary treatment was terminated for both strains at 35 wk of age due to similar low egg production. Within each strain, there was no significant difference in egg production performance for hens fed 0.14% NPP compared with hens fed 0.45% NPP. In experiment 2,3 diets with varying levels of NPP (0.10, 0.13, and 0.45%) were fed to 5 replicate groups of 12 hens of each Hy-Line strain from 95 to 112 wk of age. The 0.10% NPP treatment rapidly and severely depressed egg production and was terminated at 99 wk of age for both strains. In addition, egg production and egg mass were depressed similarly in both strains fed 0.13% NPP. In conclusion, this research indicates that Hy-Line W-36 and Hy-Line W-98 hens responded similarly to dietary NPP deficiency, suggesting that both strains have similar NPP requirements.

Aleukemic monocytic leukemia cutis.

Aleukemic leukemia cutis is a rare condition in which leukemic cells invade the skin before they appear in peripheral blood or bone marrow specimens. Herein we describe a 67-year-old man who underwent assessment because of papules and nodules on his back and lower extremities. A biopsy of these lesions confirmed a dense, predominantly monocytic infiltrate of the dermis and subcutaneous tissue. Immunohistochemical stains were positive for CD43 (Leu-22) as well as monocytic markers. Bone marrow and peripheral blood examinations failed to reveal leukemia. Treatment was based on the results of the skin biopsy, and the patient is doing well 1 year after therapy.

Lymphoma associated with human immunodeficiency virus infection.

OBJECTIVE: To describe lymphoma associated with human immunodeficiency virus (HIV) infection. DESIGN: A review of HIV-related lymphoma and its associated epidemiology, etiopathogenesis, and clinicopathologic characteristics is presented. Major studies of therapeutic regimens for HIV-related lymphoma are discussed. Factors that could contribute to a poor prognosis are summarized. RESULTS: Malignant lymphoma that develops in patients with HIV infection fulfills diagnostic criteria for the acquired immunodeficiency syndrome (AIDS). The incidence is increasing and varies by subtype of lymphoma, age, sex, race, and risk factors. B-cell hyperactivation is thought to contribute to the development of lymphoma. The mechanisms that may show transformed cell hyperproliferation and clonal expansion are HIV itself or other viruses (for example, Epstein-Barr virus), growth factors, aberrant oncogene or tumor-suppressor gene expression, and factors that induce genetic instability or DNA damage or alter host or viral genome repair. Treatment of HIV-related lymphoma is associated with toxicity, infectious complications, low rate of complete response, and brief median survival time. CONCLUSION: Persons with HIV-induced immune dysregulation have a high risk for the development of aggressive non-Hodgkin's lymphoma characterized by histologic evidence of a high-grade malignant process, B-cell phenotype, an unusual extranodal involvement, and a poor prognosis. The potential role of specific viruses, antiviral treatments, and other therapeutic strategies are future areas of investigation.

Granulomatous vasculitis associated with herpes virus: a persistent, painful, postherpetic papular eruption.

Cutaneous granulomatous vasculitis manifesting as a postherpetic reaction pattern is uncommon hand has previously been reported as a delayed complication of varicella-zoster virus infection. We describe three patients who had persistent, painful, postherpetic papules in a zosteriform distribution that histologically demonstrated a small vessel granulomatous vasculitis. Herpes simplex virus DNA detected by the polymerase chain reaction technique was demonstrated in two cases.

Bovine aortic and human dura mater valves: a comparative study in artificial hearts in calves.

Thirty-one glutaraldehyde-treated bovine aortic valves (BAVs) and 105 glycerol-treated human dura mater valves (HDVs) were used in 51 various artificial hearts up to 316 days in calves. Multiple valves were implanted in the same animal under different hemodynamic conditions. A comparative study of these valves was performed in terms of blood compatibility and durability with relation to the different hemodynamic environments. Both BAVs and HDVs showed good blood compatibility. The degradation of collagen bundles of the valves began as early as 7 days in BAVs and 13 days in HDVs, and was seen in the hinged portions of the cusps. The fiber separation and resultant void formation were followed with insudation of blood elements and subsequent calcification. Calcification was dystrophic in nature and was encountered in 70.9% of BAVs and 7.6% of HDVs. All 17 BAVs used more than 30 days were calcified; in HDVs the earliest calcified lesion was seen in a 78 day specimen. The pathological changes were more severe in the left side than the right of the total artificial hearts. These results clearly indicated that the HDV is more durable than the glutaraldehyde-treated BAV. It was suggested that degradation of these tissue valves is greatly affected by the degree of hemodynamic stress on the valve cusp. Although glutaraldehyde treatment has increased the durability of tissue valves in general, the structure of the valve tissue also plays an important role in long-term durability.

The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.

BACKGROUND: Thiopurine methyltransferase (TPMT) is one of three major enzymes involved in the metabolism of azathioprine and its active metabolite 6-mercaptopurine. Thiopurine methyltransferase activity is determined by an allelic polymorphism for either high (TPMTH) or low (TPMTL) enzyme activity. Homozygotes for the low activity allele are known to be at risk for profound myelosuppression with azathioprine. Heterozygotes may be at risk for myelosuppression. Homozygotes for the high activity allele may be inadequately immunosuppressed with conventional, empiric doses of azathioprine. We analyzed TPMT activity in red blood cell (RBC) lysates and determined the TPMT genotypes (based on normal population screening) of 28 dermatologic patients. This information was correlated with the observed efficacy and side effects of azathioprine therapy. OBSERVATIONS: Two patients with TPMT levels of less than 12.5 U/mL RBCs (both TPMTH heterozygotes) experienced leukopenia (white blood count < 4.0 x 10(9)/L) with azathioprine doses around 1.5 mg/kg. A third patient who experienced leukopenia had a TPMT level at the lower end of the homozygous range (15.5 U/mL RBCs) but received the highest dose of azathioprine (2.6 mg/kg) of all patients in this series. Ten patients with TPMT levels of more than 18.5 U/mL RBCs (all TPMTH homozygotes) receiving less than 1.5 mg/kg of azathioprine were judged to have a poor clinical response. In comparison, seven patients with TPMT levels between 12.5 and 18.5 U/mL RBCs (six TPMTH homozygotes and one TPMTH heterozygote) receiving 0.9 to 1.8 mg/kg of azathioprine had a favorable clinical response. Adverse effects of gastrointestinal upset and liver function test abnormalities did not appear to correlate with TPMT activity. CONCLUSION: The TPMTH heterozygotes may be at increased risk for myelosuppression with standard, empiric doses of azathioprine. On the other hand, homozygotes for TPMTH, particularly those with TPMT levels at the upper end of the homozygous range, may have a poor clinical response to azathioprine due to inadequate empiric dosing.

Phytase effects on amino acid digestibility in molted laying hens.

Two hundred sixteen previously molted Dekalb Delta Leghorn laying hens (78 wk of age) were utilized to determine the effect of phytase on the ileal digestibility of amino acids. The hens were randomly arranged in a 3 x 2 factorial to evaluate three diet types that were corn-soybean meal (C-SBM), C-SBM-meat and bone meal (C-SBM-MBM), and C-SBM-wheat middlings (C-SBM-WM) and two levels of phytase (0 or 300 U/kg of diet). Each treatment was administered to four replicates of nine hens per replicate. Hens were fed the experimental diets for 21 d, and daily egg production and feed intake were recorded. After 21 d, the hens were euthanized, and ileal contents were collected for amino acid and digestible energy determination. Egg production of the hens did not differ among the treatments (P > 0.05). A significant interaction between diet type and phytase level for Ala, Gly, Leu, and Met was observed. The interaction resulted because phytase numerically increased amino acid digestibilities for the C-SBM-MBM and C-SBM-WM diets, but phytase addition numerically decreased the amino acid digestibilities for the C-SBM diet. Diet type had a significant effect on digesibilites of most amino acids. The latter effect was due primarily to lower amino acid digestibilities for the C-SBM-MBM diet than the C-SBM-WM diet. Phytase had no significant affect on digestibility of any amino acid. Ieal digestible energy was significantly affected by diet type but not by phytase. In conclusion, diet type had a significant effect on apparent ileal amino acid digestibility and digestible energy, but phytase had no consistent effect.

Phytase, citric acid, and 1alpha-hydroxycholecalciferol improve phytate phosphorus utilization in chicks fed a corn-soybean meal diet.

Previous research from our laboratory has shown that phytase, citric acid, and 1alpha-hydroxycholecalciferol [1alpha-(OH) D3] individually improve phytate P use in young chicks fed a P-deficient corn-soybean meal (C-SBM) diet. The current study was conducted to evaluate combinations of these additives on phytate P utilization. In 3 chick experiments, male crossbred chicks (New Hampshire x Columbian) were fed experimental diets from 8 to 21 d of age. The C-SBM basal diet used in all assays contained no supplemental P and was calculated to provide 23% CP, 0.13% nonphytate P (0.39% total P), 0.62% Ca, 25 mg of cholecalciferol/kg, and 3,260 kcal of TME/kg. In all 3 experiments, factorial arrangements (2 x 2 or 2 x 2 x 2) were used to evaluate 2 levels of phytase (0 and 300 units/kg), citric acid (0 and 3 or 4%), and 1alpha(OH) D3 (0 and 5, 10, or 15 microg/kg). Phytase, citric acid, and 1alpha-(OH) D3 each increased weight gain and tibia ash in all 3 experiments. There were some significant interactions among the compounds, but these were not consistent across experiments. Using standard curve methodology for tibia ash data, it was estimated that 0.03, 0.02, and 0.04% P were released by 3% citric acid, 300 units of phytase/kg, and 5 microg 1alpha-(OH) D3/kg, respectively, and that the combination of all 3 compounds resulted in the release of 0.13% P. Our results indicate that all 3 compounds increased phytate P use, and that their effects were generally additive, with some possible synergism between citric acid and 1alpha-(OH) D3.

1alpha-hydroxycholecalciferol has little effect on phytate phosphorus utilization in laying hen diets.

Previous research in our laboratory demonstrated marked increases in phytate P utilization when P-deficient corn-soybean meal diets were supplemented with 1a-hydroxycholecalciferol [1alpha-(OH) D3] and fed to chicks. Our objective was to determine if 1alpha-(OH) D3 would improve phytate P utilization when supplemented to vitamin D-adequate laying hen diets. The five experimental treatments were 1) P-deficient corn-soybean basal diet [17% CP, 3.8% Ca, and 0.10% nonphytate NPP)], 2) basal with 2.5 microg/kg 1alpha-(OH) D3, 3) basal with 5 microg/kg 1alpha-(OH) D3, 4) basal with 10 microg/kg 1alpha-(OH) D3, and 5) basal with 0.35% supplemental inorganic P (0.45% NPP, positive control). Diets were fed to six replicate groups of 12 HyLine W-98 White Leghorn laying hens from 44 to 52 wk of age. Hen-day egg production was significantly depressed by 47 wk of age for the basal diet treatment and by 47, 49, and 48 wk of age, respectively, for the 2.5, 5, and 10 microg/kg of 1alpha-(OH) D3 treatments compared to the positive control diet. Supplementation with 5 or 10 microg/kg 1alpha-(OH) D3 did improve (P < 0.05) egg production, but egg production for those treatments was much lower than that for the 0.45% NPP treatment. Our results indicate that 1alpha-(OH) D3 did not substantially improve P utilization in laying hens fed corn-soybean meal diets.

Citric acid does not improve phosphorus utilization in laying hens fed a corn-soybean meal diet.

Data previously obtained from our laboratory have indicated that citric acid was very effective at improving phytate-P utilization in chicks fed a P-deficient corn-soybean meal (SBM) diet. The objective of the current study was to determine if citric acid would have similar effects in a commercial strain of Single Comb White Leghorn laying hens (n = 432) fed a corn-SBM diet containing 0.10% available P (AP). Dietary treatments were a corn-SBM basal diet (0.10% AP, 3.8% Ca, and 17% CP) supplemented with 0, 1, 2, 3, or 4% citric acid and a positive control diet containing 0.45% AP. Each of the six dietary treatments were fed to six replicate groups of 12 hens from 22 to 40 wk of age. No significant differences in performance were observed among treatments during the first 4 wk of the experiment. Hen-day egg production, feed consumption, feed efficiency, and egg yield were subsequently depressed in hens fed 0, 1, 2, 3, or 4% citric acid compared with hens fed 0.45% AP. The results of this study indicate that citric acid does not improve the utilization of dietary P in laying hens fed a corn-SBM diet containing 3.8% Ca.

The effect of citric acid on the calcium and phosphorus requirements of chicks fed corn-soybean meal diets.

Data previously reported from our laboratory indicated that supplementation of a corn-soybean meal diet with citric acid improves P utilization in chicks. The four experiments reported herein were conducted to further evaluate the effects of citric acid on Ca and P utilization for chicks fed a corn-soybean meal diet. Diets in all experiments were fed to chicks from 8 to 21 or 22 d of age. The first experiment evaluated the effect of 6% citric acid on the Ca requirement of chicks. A Ca-deficient basal diet [23% CP, 0.54% Ca, 0.45% available P (AP)] containing 0 to 0.7% supplemental Ca in 0.1% increments was fed with or without 6% citric acid. The results indicated that citric acid did not significantly affect the Ca requirement. A second experiment evaluated different levels of citric acid (0, 2, 4, or 6%) on P utilization, and results indicated that 4 and 6% citric acid produced the largest responses in growth and tibia ash. Experiments 3 and 4 were then conducted to determine whether 4 or 6% citric acid would reduce the level of supplemental P required. Dietary treatments were a P-deficient basal diet (23% CP, 1.0 or 1.3% Ca, 0.20% AP) supplemented with 0 to 0.25% inorganic P with or without 4 or 6% citric acid. When diets contained citric acid, weight gain and tibia ash were maximized at lower AP levels than when diets contained no citric acid. The results of this study indicate that citric acid increases P utilization in corn-soybean meal diets and reduces the AP requirement by approximately 0.10% of the diet.

Minimum phosphorus requirement of one-cycle and two-cycle (molted) hens.

In experiment 1 (one cycle), hens were fed diets containing 0.10, 0.115, 0.125, 0.135, 0.15, or 0.45% available P (AP) from 40 to 56 wk of age, with the last diet being a positive control. Egg production, egg mass, and BW were reduced (P < 0.05) by all lower AP levels except 0.15% AP when compared with the 0.45% AP treatment. In the second experiment (two cycles with a molt), hens were initially fed diets containing 0.10, 0.12, 0.14, 0.16, 0.18, 0.20, or 0.45% AP from 21 to 63 wk of age. Diets containing 0.10, 0.12, and 0.14% AP were terminated at 35, 39, and 50 wk, respectively, due to low egg production and increased mortality. Hens fed 0.16% AP also had significantly lower production performance than hens fed 0.45% AP during the first cycle. Hens on the 0.16 to 0.45% AP treatments were induced molted at 64 wk of age by 10 d of feed removal. The hens were then returned to the same AP layer diet they had been fed from 21 to 63 wk. For the 68 to 108 wk postmolt second-cycle period, hens fed the 0.16 to 0.20% AP diets (166 to 209 mg/d) had significantly lower egg production, egg mass, and feed efficiency than hens fed 0.45% AP. The results of our study indicated that first-cycle hens required approximately 0.18% AP or 198 mg AP/hen per day, and molted hens in their second cycle had a requirement that was greater than 0.20% AP or 209 mg AP/hen per day.

Efficacy of high available phosphorus corn in laying hen diets.

Our objective was to determine if high available phosphorus corn would provide sufficient available phosphorus (AP) to laying hens fed corn-soybean meal diets from 57 to 69 wk of age. Six replications of 12 Dekalb Sigma Leghorn hens were fed a normal yellow dent (YD) corn-soybean meal diet or high available phosphorus (HAP) corn-soybean meal diet without and with 0.04% supplemental inorganic P. The unsupplemented YD diet was calculated to contain 17% CP, 3.8% Ca, and 0.10% AP, and the unsupplemented HAP diet contained 17% CP, 3.8% Ca, and 0.16% AP. In addition, a positive control, YD diet (17% CP, 3.8% Ca, 0.45% AP) was also fed. The HAP corn was directly substituted for YD on a weight basis, and the amount of soybean meal was kept constant in all diets. Egg production, hen body weight, egg weight, egg mass, feed consumption, and feed efficiency were measured. The YD and the YD + 0.04% P treatments were terminated at 61 and 65 wk of age, respectively, due to severe depressions in egg production. Egg production and egg mass for hens fed HAP diets were not different (P > 0.05) from those of hens fed the 0.45% AP diet; however, hens fed the unsupplemented HAP diet did have lower hen body weights and feed intake (P < 0.05) compared to hens fed the positive control diet. Our results indicate that HAP corn contains more available P than normal YD corn and that hens can be fed HAP corn-soybean meal diets containing little or no P supplementation with only minimal effects on production performance.

Efficacy of phytase for increasing protein efficiency ratio values of feed ingredients.

Data previously reported in several studies have suggested that phytase improves amino acid digestibility in chicks. It was the objective of the current study to determine if phytase would increase the protein efficiency ratio (PER) values (g weight gain per g protein intake) for several feed ingredients fed to chicks. Six experiments were conducted and ingredients evaluated were casein, soybean meal, canola meal, cottonseed meal, peanut meal, wheat middlings, wheat bran, rice bran, defatted rice bran, meat and bone meal, and corn gluten meal. Casein was evaluated to serve as a phytate-free control ingredient. Each feedstuff was analyzed for CP and included in cornstarch:dextrose diets as the only source of protein to provide 10% dietary protein in Experiments 1 to 5 or 18% dietary protein (soybean meal) in Experiment 6. Dietary Ca and nonphytate P levels were varied among experiments and ranged from 0.95 to 1.5% Ca and 0.35 to 0.675% nonphytate P. The test ingredient diets were fed with 0 or 1,200 units of phytase/kg to New Hampshire x Columbian chicks from 8 to 17 or 20 d of age. The PER values varied greatly among ingredients, ranging from 1.4 for corn gluten meal to 4.2 for canola meal. Phytase addition had no significant effect (P > 0.10) on PER values for any of the ingredients evaluated, except for an increase for casein in one experiment. The results indicated that 1,200 U of phytase/kg did not significantly increase protein utilization of several feed ingredients as assessed by a PER chick growth assay.

Sales force can lead to dollars for OH (occupational health) services.

As hospitals enter the 1990s, one of the challenges they will face is finding additional sources of revenue. Occupational Health (OH) programs offer an opportunity for increased dollars--but only for hospitals willing to use sales tactics common to corporate America. In the following article, the author tells how an institution can sell OH services.

Occupational health programs can generate new revenue.

A hospital may find an untapped source of revenue by setting up occupational health services. Starting with treatment of workers' compensation cases, an occupational health program may open the door to additional revenue through family practice or group health plans. A preliminary feasibility study of market conditions, operational needs, and potential obstacles is essential to successful program management.

Sales: evaluating the return on investment.

In this article, a case study is presented to illustrate the ways in which sales programs have evolved in healthcare organizations over the last few years. The importance of developing a system of tracking sales so revenues can be tied to sales efforts is emphasized.

Evaluation of NutriDense low-phytate corn and added fat in growing and finishing swine diets.

Two experiments were conducted to evaluate the effects of NutriDense low-phytate corn in conjunction with increasing added dietary fat on growing and finishing pig performance. Diets in both experiments were corn-soybean meal-based, with yellow dent or NutriDense low-phytate corn and 0, 3, or 6% added choice white grease arranged in a 2 x 3 factorial design. There were 25 to 28 pigs per pen and 7 pens (replications) per treatment in both experiments. In Exp. 1, a total of 1,162 gilts with an initial BW of 44.6 kg were used in a 28-d growth study. A constant true ileal digestible (TID) Lys:ME ratio of 2.80 g/Mcal and available P:ME ratio of 0.90 g/Mcal were maintained in all treatment diets. Overall (d 0 to 28), there were no corn source x added fat interactions (P >/= 0.79). Regardless of corn source, ADG and G:F increased (linear, P = 0.03) with increasing added fat. There were no differences (P >/= 0.34) in pig growth performance between those fed NutriDense low-phytate or yellow dent corn. In Exp. 2, a total of 1,128 gilts with an initial BW of 81.6 kg were used in a 28-d growth study. A constant TID Lys:ME ratio of 2.15 g/Mcal of ME and available P:ME ratio of 0.75 g/Mcal were maintained in all treatment diets. Overall (d 0 to 28), there was a tendency (P = 0.07) for a corn source x added fat interaction for G:F, which can be explained by the improved G:F in pigs fed yellow dent corn only when 6% fat was added to the diet, whereas G:F was improved at both 3 and 6% added fat in pigs fed NutriDense low-phytate corn. There were no differences (P >/= 0.18) in growth performance between pigs fed NutriDense low-phytate or yellow dent corn. These results indicate that increasing added fat improved growth performance regardless of the corn source. In addition, growth performance was similar for pigs fed NutriDense low-phytate or yellow dent corn.